Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
NCT07276763 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 16509
Last updated 2025-12-11
Summary
A retrospective observational study to explore the impact of discontinuing GLP-1 receptor agonists for two weeks prior to upper endoscopy on the risk of gastric retention
Conditions
- Gastric Retention
Interventions
- OTHER
-
No Intervention: Observational Cohort
No Intervention: Observational Cohort
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Danian Ji, M.D. · Huadong Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-10
- Primary Completion
- 2025-12-15
- Completion
- 2025-12-15
Countries
- China
Study Locations
More Related Trials
-
Outcome of Gastric Fundus and Pylorus Botulinum Toxin A Injection
NCT04948177 ·Status: COMPLETED
-
Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity
NCT02191501 ·Status: TERMINATED ·Phase: NA
-
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
NCT06987669 ·Status: NOT_YET_RECRUITING
-
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
NCT02417103 ·Status: TERMINATED ·Phase: PHASE3
-
Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists
NCT05889637 ·Status: COMPLETED
-
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
NCT06500143 ·Status: COMPLETED
-
RESCUE: Discontinuation of GLP-1
NCT07190794 ·Status: RECRUITING
-
Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
NCT06038734 ·Status: COMPLETED
-
Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Non-diabetic Controls
NCT03217630 ·Status: COMPLETED
-
Nonsurgical Reversible Obesity Treatment (NROT1)
NCT05420506 ·Status: UNKNOWN ·Phase: NA
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
NCT06734312 ·Status: RECRUITING ·Phase: NA
-
Body Surface Gastric Mapping in Patients on Semaglutide
NCT06401746 ·Status: RECRUITING
-
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
NCT07335731 ·Status: RECRUITING ·Phase: NA
-
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
NCT06292065 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Sleeve Gastroplasty for Treatment of Obesity
NCT02231970 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Role of Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injection in the Treatment of Obesity.
NCT03901040 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness Gastric Balloon in Obese Adolescents
NCT04209842 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Semaglutide Study
NCT06420739 ·Status: ACTIVE_NOT_RECRUITING
-
Gastric and Autonomic Functions in Patients With Intragastric Balloon
NCT03530410 ·Status: WITHDRAWN
-
Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric Plication
NCT01077193 ·Status: TERMINATED ·Phase: NA
-
Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial
NCT05516576 ·Status: RECRUITING ·Phase: NA
-
Evaluation of a 6-month Intragastric Balloon
NCT06585371 ·Status: NOT_YET_RECRUITING
-
Endoscopic Gastric Reduction for Weight Management
NCT01682733 ·Status: COMPLETED ·Phase: PHASE1
-
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
NCT07237750 ·Status: RECRUITING ·Phase: NA
-
Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery
NCT07310875 ·Status: NOT_YET_RECRUITING ·Phase: NA